Articles: chronic.
-
COPD Comorbidity PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Our aim was to study the vascular reactivity of patients with stable COPD and to try to correlate endothelial dysfunction, vascular reactivity and functional capacity of these patients that eventually may lead to cardiovascular mortality ⋯ The following authors have nothing to disclose: Claudia Simsolo, Arnon BlumNo Product/Research Disclosure Information.
-
DVT/PE PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To outline the resource use and costs a U.S. health plan can anticipate during the evaluation and first year of treatment of a CTEPH patient ⋯ Vijay Joish: Employee: employee of bayer sponsor of study Christine Divers: Employee: employee of bayer sponsor of study Chakkarin CBurudpakdee: Consultant fee, speaker bureau, advisory committee, etc.: consultant of bayer sponsor of study Anshul Shah: Consultant fee, speaker bureau, advisory committee, etc.: consultant of bayer sponsor of study Stephen Mathai: Consultant fee, speaker bureau, advisory committee, etc.: consultant to bayer sponsor of studyNo Product/Research Disclosure Information.
-
Cancer Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Inflammatory psedotumor of the lung is a rare, quasineoplastic lung tumor of unknown etiology. It occurs most often in young adults ⋯ Although pulmonary inflammatory pseudotumors are considered benign, they can be very aggressive locally or cause metastasis. The differential diagnosis is usually with lung cancer and the deffinitive diagnosis is made on histopathological exam. If possible, complete surgical resection is necessary and can cure the disease. Extended follow-up is required in these patients.Reference #1: Surgical management of pulmonary inflammatory pseudotumors: a single center experience. Mondello B, Lentini S, Barone M, Barresi P, Monaco F, Familiari D, La Rocca A, Sibilio M, Acri IE, David A, Monaco M. J Cardiothorac Surg. 2011 Feb 23;6:18. doi: 10.1186/1749-8090-6-18. PMID:21345228DISCLOSURE: The following authors have nothing to disclose: Ionela Belaconi, Claudia Toma, Stefan Dumitrache-Rujinski, Alina Croitoru, Miron BogdanNo Product/Research Disclosure Information.
-
Tuberculosis Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: In the Philippines, tuberculosis (TB, has been one of the most common causes of hemoptysis. This case report presents a patient with hemoptysis that may be a sequelae of chronic TB. However, further investigation reveals a concomitant non-tuberculous mycobacterial (NTM) infection and the co-existence of aspergilloma aggravating the condition. ⋯ The co-exsistence of NTM and Aspergilloma may complicate hemoptysis in a patient with an underlying chronic pulmonary insult. All efforts must be exhausted and diagnostic armaments be maximized in order to promptly address the needs of the patient.Reference #1: Non-tuberculous mycobacterial lung infection complicated by chronic necrotising pulmonary aspergillosis. I Hafeez,M F Muers, S A Murphy,E G V Evans, R C Barton, P McWhinney. Thorax 2000;55:717-719Reference #2: Coexistence of intracavitary fungal colonization (fungusball) and active tuberculosis. GISELA UNIS, PEDRO DORNELLES PICON(TE SBPT), LUIZ CARLOS SEVERO. J Bras Pneumol 2005; 31(2): 139-43.Reference #3: Emerging of Mycotic Infection in Patients Infected with Mycobacterium tuberculosis. Sunita Bansod and Mahendra Rai. World Journal of Medical Sciences 3 (2): 74-80, 2008DISCLOSURE: The following authors have nothing to disclose: John Noel Chan, Shirley Jane Panganiban, Angelo Adraneda, Jonathan Paolo RustiaNo Product/Research Disclosure Information.
-
Respiratory InfectionsSESSION TYPE: Slide PresentationsPRESENTED ON: Sunday, March 23, 2014 at 04:15 PM - 05:15 PMPURPOSE: Community-acquired MRSA (CA-MRSA) pneumonia is an uncommon but potentially life-threatening disease. MRSA is generally not covered when treating CAP. Several small case series have described these patients. Certain clinical characteristics have been proposed that suggest MRSA as a pathogen. However, when to consider CA-MRSA is a subject of ongoing debate. The current study reviewed the risk factors, presentation, and outcomes of patients with CA-MRSA pneumonia in an urban community hospital. ⋯ The following authors have nothing to disclose: Kunal Patel, Viral Patel, Kelly Cervellione, Craig ThurmNo Product/Research Disclosure Information.